By Cristina Roca
Sanofi SA said Friday that net profit rose in the fourth quarter, and that it expects its business earnings per share to grow this year.
The French pharmaceutical company said that net profit came in at 1.13 billion euros ($1.29 billion) for the period, up from EUR1.07 billion for the same period last year.
Sales came in at EUR9.99 billion, up from EUR9.38 billion, the company said. A consensus estimate provided by FactSet saw sales at EUR10.4 billion for the quarter.
Business net income stood at EUR1.73 billion in the October-December period, up 13% from the previous year, Sanofi said.
Sales of Sanofi’s growth driver Dupixent rose 53% on year in the quarter at constant exchange rates, helping specialty care become Sanofi’s largest unit by sales.
For 2022, the company expects its business EPS to have low double-digit growth at constant exchange rates, “barring unforeseen major adverse events,” it said.
Write to Cristina Roca at email@example.com